Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Sep 10, 2024
- Accession no.
- 0001493152-24-035684
- Filed
- Sep 10, 2024
- Trade date
- Sep 9-10, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $114.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −34,592 | $1.89 | −$65,378.88 | 2,118,935 | Indirect | |
| Sep 9, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −1,900 | $1.89 | −$3,591 | 54,600 | Indirect | |
| Sep 10, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −24,000 | $1.77 | −$42,480 | 2,094,935 | Indirect | |
| Sep 10, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −1,500 | $1.77 | −$2,655 | 53,100 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.